Valuation check: HGEN's profit margin is -3137.32%, below the Healthcare sector average of 19.13%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2023
Trailing 12 months ending Mar 2023
The latest profit margin for HGEN is -3137.32% as of March 2023. That compares with -4641.13% in the prior-year period — up 32.4% year over year. That is below the Healthcare sector average of 19.13%. Investors often review this figure alongside Humanigen's historical trend and sector peers before judging valuation or financial health.
Over the past year, HGEN's profit margin moved from -4641.13% to -3137.32% — a 32.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Humanigen's valuation or profitability profile.
Against Healthcare companies, HGEN currently prints -3137.32% for profit margin, while the sector average sits near 19.13%. That is roughly 16498.9% below the sector mean. Large gaps often invite a closer look at Humanigen's growth, margins, and balance sheet.
Profit Margin shows how effectively Humanigen converts resources into returns. At -3137.32%, HGEN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -4641.13% in the prior-year period — up 32.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting HGEN's profit margin (-3137.32%), review year-over-year change from -4641.13%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.